Nkarta (NKTX) Current Leases (2019 - 2026)
Nkarta (NKTX) posted quarterly Current Leases of $7.1 million for Q1 2026, up 19.01% year-over-year from $6.0 million in Q1 2025, and up 2.79% quarter-over-quarter from $6.9 million in Q4 2025.
Nkarta (NKTX) Current Leases (2019 - 2026) Analysis & Trends
Nkarta's Current Leases history runs 8 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- In Q1 2026, Current Leases rose 19.01% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (up 19.01% YoY), while the FY2025 annual figure was $6.9 million, up 13.87% from the prior year.
- Current Leases for Q1 2026 stood at $7.1 million, up from $6.9 million in the prior quarter.
- The five-year high for Current Leases was $7.1 million in Q1 2026, with the low at $2.5 million in Q1 2022.
- The 5-year median for Current Leases is $6.0 million (2023), against an average of $5.7 million.
- The sharpest annual moves came in 2023 and 2024: Current Leases surged 129.62% in 2023, then declined 8.56% in 2024.
- Nkarta's Current Leases stood at $4.2 million in 2022, then surged by 42.83% to $6.1 million in 2023, then declined by 0.31% to $6.0 million in 2024, then climbed by 13.87% to $6.9 million in 2025, then increased by 2.79% to $7.1 million in 2026.
- Business Quant data shows NKTX's Current Leases at $7.1 million in Q1 2026, $6.9 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Nkarta | 195.92 Mn | 195.92 Mn | - | 7.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.28 Mn |
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 5.95 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 6.08 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 6.05 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.46 Mn |